These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 33506730

  • 61. Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study.
    Corral M, DeYoung K, Kong AM.
    BMC Pulm Med; 2020 Jul 11; 20(1):188. PubMed ID: 32652979
    [Abstract] [Full Text] [Related]

  • 62. Association Between Cognitive Function and Health Care Costs 3 Months and 6 Months After Initiating Antidepressant Medication for Depressive Disorders.
    Walker V, Patel H, Kurlander JL, Essoi B, Yang J, Mahableshwarkar AR, Samp JC, Akhras KS.
    J Manag Care Spec Pharm; 2015 Sep 11; 21(9):742-52, 752a-752e. PubMed ID: 26308222
    [Abstract] [Full Text] [Related]

  • 63. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
    Yen L, Wu J, Hodgkins PL, Cohen RD, Nichol MB.
    J Manag Care Pharm; 2012 Sep 11; 18(9):701-12. PubMed ID: 23206213
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E, Dye JT, Hall B, Ndehi L, Schwab P, Vaccaro J.
    J Manag Care Spec Pharm; 2019 Jun 11; 25(6):688-695. PubMed ID: 31134865
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs.
    Murage MJ, Princic N, Park J, Malatestinic WN, Zhu B, Atiya B, Kern SA, Stenger KB, Sprabery AT, Ogdie A.
    J Manag Care Spec Pharm; 2022 Feb 11; 28(2):206-217. PubMed ID: 35098751
    [Abstract] [Full Text] [Related]

  • 69. One-Year Outcomes of an Integrated Multiple Sclerosis Disease Management Program.
    Groeneweg M, Forrester SH, Arnold B, Palazzo L, Zhu W, Yoon P, Scearce T.
    J Manag Care Spec Pharm; 2018 May 11; 24(5):458-463. PubMed ID: 29694287
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
    Lloyd JT, Maresh S, Powers CA, Shrank WH, Alley DE.
    Med Care; 2019 Mar 11; 57(3):218-224. PubMed ID: 30676355
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Development and validation of a drug adherence index for COPD.
    Bengtson LGS, Bancroft T, Schilling C, Buikema AR, Stanford RH.
    J Manag Care Spec Pharm; 2021 Feb 11; 27(2):198-209. PubMed ID: 33506734
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J, Lingohr-Smith M, Kwong WJ.
    J Manag Care Pharm; 2014 Feb 11; 20(2):174-86. PubMed ID: 24456319
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.